Health agencies to set price targets as part of Trump’s executive order to slash U.S. drug prices
President Trump signed an executive order implementing a Most-Favored-Nation pricing model to align U.S. drug costs with the lowest global prices. The policy targets brand-name drugs without competition, potentially saving $88 billion over seven years and ending “foreign freeriding” on U.S. innovation. Pharmaceutical companies must…